Personalized Performance Optimization Platform
NCT: NCT06979570 · TERMINATED
Brief Summary
Crews of future long-duration exploration missions will have to cope with a wide range of stressors that present significant challenges for maintaining optimal performance. Crews will have to operate under conditions of high workload, reduced sleep and circadian dysregulation, limited sensory stimulation, confinement and extended separation from family and friends, and communication delays isolating them from real-time interaction with ground support, which may be particularly critical in the event of emergencies. These factors present significant risks to optimal cognitive/behavioral functioning and performance, across individuals and teams, and such challenges will only increase in criticality as human exploration moves beyond Earth's orbit to targets such as the Moon and Mars. To help mitigate these risks, Massachusetts General Hospital, along with collaborators at the Massachusetts Institute of Technology, will investigate a novel, personalized and scalable, closed-loop platform technology for on-board behavioral health management-one which adapts the local working environment to optimize performance based on biosensor feedback.
Frequently Asked Questions
What is Personalized Performance Optimization Platform?
Personalized Performance Optimization Platform is a clinical trial registered under NCT06979570. Current status: TERMINATED.
What is the status of NCT06979570?
The current status of NCT06979570 (Personalized Performance Optimization Platform) is: TERMINATED.
When did Personalized Performance Optimization Platform start?
Personalized Performance Optimization Platform started on 2021-02-22.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.